LAURUSLABS

Pharmaceuticals

Laurus Labs Limited

NSE: LAURUSLABSBSE: 540222ISIN: INE947Q01028

₹1,601.20

+32.90 · +2.10%

As of 24 Jul 2026

Open

₹1,560.00

High

₹1,610.00

Low

₹1,554.90

Prev Close

₹1,568.30

52W High

₹1,610.00

52W Low

₹810.05

Volume

26.47 L

Mkt Cap

₹86,294 Cr

Fundamentals

Valuation & profitability

Market Cap

₹86,294 Cr

P/E Ratio

143

EPS (TTM)

₹11.20

Book Value

₹76.30

Dividend Yield

0.46%

ROCE

6.6%

ROE

3.97%

Sales Growth

Face Value

₹2.00

Key highlights

Auto-generated from live data

Trades at a P/E of 143, with a return on equity (ROE) of 3.97%.
LAURUSLABS is trading above all of its key moving averages (10/20/50/100/200-DMA) — a bullish technical setup.
Year-to-date it is up 42.43%, and up 57.25% over the past year.
At ₹1,601.20 it sits about 99% of the way up its 52-week range (₹810.05–₹1,610.00).
Offers a dividend yield of 0.46%.
Market capitalisation stands at ₹86,294 Cr.

Price chart

Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC

Shareholding pattern

Shareholding data syncs daily.

Performance

Stock returns vs Nifty 50

10D

+1.21%

Nifty -0.64%

20D

+3.68%

Nifty -1.72%

50D

+13.32%

Nifty +2.68%

100D

+43.39%

Nifty -1.14%

200D

+43.00%

Nifty -8.93%

YTD

+42.43%

Nifty -8.59%

52W

+57.25%

Nifty -7.86%

Moving averages

Simple moving averages vs current price

5/5 above · Bullish

SMA 10-Day

₹1,566.04Above

SMA 20-Day

₹1,538.14Above

SMA 50-Day

₹1,447.62Above

SMA 100-Day

₹1,264.61Above

SMA 200-Day

₹1,129.92Above

Price ranges

Where the price sits in each window

10-Day range₹1,601.20

₹1,520.40₹1,610.00

20-Day range₹1,601.20

₹1,448.20₹1,610.00

50-Day range₹1,601.20

₹1,283.10₹1,610.00

200-Day range₹1,601.20

₹827.25₹1,610.00

YTD range₹1,601.20

₹917.95₹1,610.00

52-Week range₹1,601.20

₹810.05₹1,610.00

Technical signals

Unfilled gaps acting as support / resistance

Unfilled Gap Up On 08 Apr, 2026 : 1072.10 ~ 1071.40SUPPORT

Unfilled Gap Up On 28 May, 2025 : 604.00 ~ 603.00SUPPORT

Annual financials

Revenue, profit & EPS by financial year

Year	Revenue	Net Profit	EPS	NPM
Mar 2023	₹5,773 Cr	₹760 Cr	₹14.12	13.16%
Mar 2022	₹4,707 Cr	₹750 Cr	₹13.96	15.93%
Mar 2021	₹4,814 Cr	₹984 Cr	₹18.33	20.44%
Mar 2021	₹4,814 Cr	₹984 Cr	₹18.33	20.44%
Mar 2020	₹2,832 Cr	₹255 Cr	₹4.77	9%
Mar 2020	₹2,832 Cr	₹255 Cr	₹4.77	9%
Mar 2019	₹2,292 Cr	₹94 Cr	₹8.81	4.1%
Mar 2019	₹2,292 Cr	₹94 Cr	₹8.81	4.1%
Mar 2018	₹2,056 Cr	₹168 Cr	₹15.81	8.17%
Mar 2017	₹1,905 Cr	₹190 Cr	₹17.99	9.97%
Mar 2016	₹1,778 Cr	₹134 Cr	₹84.82	7.54%
Mar 2015	₹1,327 Cr	₹68 Cr	₹44.07	5.12%

Peer comparison

Other companies in Pharmaceuticals

Company	P/E	Book Value	Sales Growth
SUNPHARMA SUN PHARMACEUTICAL INDUSTRIES LTD.	39.1	₹98.33	10.1%
MARKSANS MARKSANS PHARMA LTD.	23.8	₹11.85	5.8%
MOREPENLAB MOREPEN LABORATORIES LTD.	20.81	₹6.43	16.6%
NEULANDLAB NEULAND LABORATORIES LTD.	23.48	₹542.16	9.35%
GUFICBIO Gufic BioSciences Ltd.	24.16	₹10.85	20.41%
DIVISLAB DIVI'S LABORATORIES LTD.	41.01	₹266.77	9.47%
DRREDDY DR.REDDY'S LABORATORIES LTD.	19.73	₹852.69	1.07%
RPGLIFE RPG LIFE SCIENCES LTD.	17.14	₹105.02	5.73%
GLAND Gland Pharma Ltd	53.6	₹242.00	—
ZYDUSLIFE Zydus Lifesciences Ltd	8.23	₹166.00	5%
SMSPHARMA SMS PHARMACEUTICALS LTD.	9.58	₹42.07	-8.73%
CIPLA CIPLA LTD.	15.36	₹209.71	0.7%

Dividend history

Per share, by ex-date

Ex-Date: 10 May 2023₹1.20

Ex-Date: 03 Nov 2022₹0.80

Ex-Date: 10 May 2022₹1.20

Ex-Date: 17 Nov 2021₹0.80

Ex-Date: 11 May 2021₹0.80

Ex-Date: 08 Feb 2021₹0.40

Ex-Date: 10 Nov 2020₹0.80

Ex-Date: 01 Jul 2020₹1.00

Ex-Date: 23 Mar 2020₹1.50

Ex-Date: 03 Jul 2019₹1.50

Ex-Date: 28 Jun 2018₹1.50

Ex-Date: 06 Jul 2017₹1.50

Bulk & block deals

Recent large transactions

Date	Client	Type	Qty	Price
25 Oct 2022	ISHARES CORE EMERGING MARKETS MAURITIUS CO	SALE	2,84,783	₹479.80
25 Oct 2022	ISHARES CORE MSCI EMERGING MARKETS ETF	PURCHASE	2,84,783	₹479.80
25 Oct 2022	ISHARES INDIA SC MAURITIUS COMPANY	SALE	2,10,010	₹479.80
25 Oct 2022	ISHARES MSCI INDIA SMALL-CAP ETF	PURCHASE	2,10,010	₹479.80
17 Oct 2022	ISHARES CORE EMERGING MARKETS MAURITIUS CO	SALE	4,47,533	₹516.10
17 Oct 2022	ISHARES CORE MSCI EMERGING MARKETS ETF	PURCHASE	4,47,533	₹516.10
17 Oct 2022	ISHARES INDIA SC MAURITIUS COMPANY	SALE	69,957	₹516.10
17 Oct 2022	ISHARES MSCI INDIA SMALL-CAP ETF	PURCHASE	69,957	₹516.10
11 Oct 2022	ISHARES CORE EMERGING MARKETS MAURITIUS CO	SALE	4,37,620	₹516.60
11 Oct 2022	ISHARES CORE MSCI EMERGING MARKETS ETF	PURCHASE	4,37,620	₹516.60
11 Oct 2022	ISHARES INDIA SC MAURITIUS COMPANY	SALE	68,408	₹516.60
11 Oct 2022	ISHARES MSCI INDIA SMALL-CAP ETF	PURCHASE	68,408	₹516.60

Explore more

Pharmaceuticals sector

Sector peers & index performance

LAURUSLABS news & filings

Latest corporate announcements

Top Gainers

Biggest NSE gainers today

Top Losers

Biggest NSE losers today

IPO Calendar

Open & upcoming IPOs

Stock Screener

Find more stocks like this

Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.